Clinical trial · Interventional
A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
NCT04625413CI-TRIAL-00108795UR-GOAL 1completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a pilot study to evaluate the usability and feasibility of a patient-centered communication tool (University of Rochester-Geriatric Oncology Assessment for acute myeloid Leukemia or UR-GOAL) among 15 older patients with AML, their caregivers, and oncologists.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Myeloid Leukemia | Acute Myeloid Leukemia | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Behavioral: UR-GOAL communication tool | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Experimental: Experimental Arm: single
- description
- The UR-GOAL tool will incorporate conjoint analysis to elicit patient preferences as well as assessments of fitness and prognostic awareness.
- interventionNames
- Behavioral: Behavioral: UR-GOAL communication tool
Primary outcomes (2)
- measure
- Feasibility (Recruitment Rates)
- timeFrame
- Four weeks
- description
- Percentage of patients who consented to the study ultimately completed the study intervention and post-intervention assessment
- measure
- Usefulness
- timeFrame
- Four weeks
- description
- Usefulness was assessed using the Preparation for Decision Making Scale (mean score range from 1 to 5, and higher scores indicate greater usefulness)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria for Patients:
* Age ≥60 years (conventional definition of older age in AML)
* Newly diagnosed AML
* Considering treatment
* Able to provide informed consent
* English-speaking
Inclusion Criteria for Caregivers:
* Selected by the patient when asked if there is a "family member, partner, friend or caregiver \[age 21 or older\] with whom you discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") can be eligible for the study. A caregiver need not be someone who lives with the patient or provides direct hands-on care. A caregiver can be any person who provides support (in any way) to the patient.
* Able to provide informed consent
* English-speaking
Inclusion Criteria for Oncologists:
* A practicing oncologist
* At least one of their patients are recruited to the study
* English-speaking
Exclusion Criteria: NoneReferences
Publications (0)
Data not yet available
No reference posted for this study.